Veterinary medicines European public assessment report (EPAR): Nobivac NXT FeLV, feline leukemia (self-amplifying RNA particle) vaccine, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCPFeLV, feline calicivirosis, feline rhinotracheitis, feline panleucopenia and feline leukemia (self-amplifying RNA particle) vaccine, Status: Authorised

Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Hopledo, levodopa,carbidopa, Date of authorisation: 20/08/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Date of authorisation: 15/07/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Akynzeo, netupitant,palonosetron, Date of authorisation: 27/05/2015, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Zutectra, human hepatitis B immunoglobulin, Date of authorisation: 30/11/2009, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Aquipta, atogepant, Date of authorisation: 11/08/2023, Revision: 7, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCPChFeLV, feline calicivirosis, feline rhinotracheitis, feline panleucopenia, feline chlamydiosis (live) and feline leukemia (self-amplifying RNA particle) vaccine, Status: Authorised